A

Alembic Pharmaceuticals Ltd

Pharmaceuticals

SMALLCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 10 analysts offering recommendations for Alembic Pharmaceuticals Ltd

40%

Buy

50%

Hold

10%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio29.0147.83
PB Ratio3.716.20
Dividend Yield1.21%0.56%

Understand what these metrics mean. 

About the company

A

Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Limited is a pharmaceutical company engaged in developing formulations and active pharmaceutical ingredients (API).

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions